Who are DHA plus Vitamin D's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): lipoic acid and omega-3 fatty acids, L-arginine and liposomal vitamin C, Lutein/zeaxanthin and DHA/EPA.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/dha-plus-vitamin-d.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

DHA plus Vitamin D — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

DHA plus Vitamin D (DHA plus Vitamin D) competitive landscape: 3 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Nutritional supplement combination. Area: Pediatrics / Nutritional supplementation.

phase 3 Nutritional supplement combination Pediatrics / Nutritional supplementation Small molecule Live · refreshed every 30 min

Target snapshot

DHA plus Vitamin D (DHA plus Vitamin D) — Bambino Gesù Hospital and Research Institute. DHA (docosahexaenoic acid) and Vitamin D work together to support bone mineralization, immune function, and neurological development.

Comparator set (3 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class
DHA plus Vitamin D TARGET	DHA plus Vitamin D	Bambino Gesù Hospital and Research Institute	phase 3	Nutritional supplement combination
lipoic acid and omega-3 fatty acids	lipoic acid and omega-3 fatty acids	Oregon Health and Science University	marketed	Nutritional supplement combination
L-arginine and liposomal vitamin C	L-arginine and liposomal vitamin C	Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico	phase 3	Nutritional supplement combination
Lutein/zeaxanthin and DHA/EPA	Lutein/zeaxanthin and DHA/EPA	National Eye Institute (NEI)	phase 3	Nutritional supplement combination

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Nutritional supplement combination class)

Bambino Gesù Hospital and Research Institute · 1 drug in this class
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico · 1 drug in this class
National Eye Institute (NEI) · 1 drug in this class
Oregon Health and Science University · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). DHA plus Vitamin D — Competitive Intelligence Brief. https://druglandscape.com/ci/dha-plus-vitamin-d. Accessed 2026-06-10.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing